deltatrials
Terminated PHASE1 NCT00803179

Growth Hormone Therapy for Wasting in Cystic Fibrosis

Sponsor: University of Massachusetts, Worcester

Conditions Cystic Fibrosis
Interventions Nutropin AQ
Updated 7 times since 2017 Last updated: Nov 16, 2025 Started: Nov 30, 2008 Primary completion: Mar 31, 2012 Completion: Mar 31, 2012

A PHASE1 clinical study on Cystic Fibrosis, this trial is terminated or withdrawn. The trial is conducted by University of Massachusetts, Worcester and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Jan 2026 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Jan 2026 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE1

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE1

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE1

    First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Massachusetts, Worcester
Data source: University of Massachusetts, Worcester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Worcester, United States